Initiation of antiretroviral therapy in early asymptomatic HIV infection.
JD Lundgren, AG Babiker, F Gordin… - The New England …, 2015 - europepmc.org
Background Data from randomized trials are lacking on the benefits and risks of initiating
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
…, ADA Monforte, F De Wolf, P Reiss, JD Lundgren… - The Lancet, 2002 - thelancet.com
Background Insufficient data are available from single cohort studies to allow estimation of
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …
Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study
…, S De Wit, CA Sabin, AN Phillips, JD Lundgren… - Aids, 2003 - journals.lww.com
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among
HIV-infected persons, and to investigate any association between such risk factors, stage …
HIV-infected persons, and to investigate any association between such risk factors, stage …
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
Background With the advent of effective antiretroviral treatment, the life expectancy for
people with HIV is now approaching that seen in the general population. Consequently, the …
people with HIV is now approaching that seen in the general population. Consequently, the …
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
Background: Whether hepatitis B (HBV) coinfection affects outcome in HIV-1-infected
patients remains unclear. Objective: To assess the prevalence of HBV (assessed as HBsAg) …
patients remains unclear. Objective: To assess the prevalence of HBV (assessed as HBsAg) …
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial
JU Jensen, L Hein, B Lundgren, MH Bestle… - Critical care …, 2011 - journals.lww.com
Objective: For patients in intensive care units, sepsis is a common and potentially deadly
complication and prompt initiation of appropriate antimicrobial therapy improves prognosis. The …
complication and prompt initiation of appropriate antimicrobial therapy improves prognosis. The …
[HTML][HTML] Current epidemiology of Pneumocystis pneumonia
A Morris, JD Lundgren, H Masur… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
Pneumocystis pneumonia (PCP) has historically been one of the leading causes of disease
among persons with AIDS. The introduction of highly active antiretroviral therapy in …
among persons with AIDS. The introduction of highly active antiretroviral therapy in …
Projected life expectancy of people with HIV according to timing of diagnosis
…, CJ Smith, R Smith, V Cambiano, JD Lundgren… - Aids, 2012 - journals.lww.com
Methods: A stochastic computer simulation model of HIV infection and the effect of ART was
used to estimate life expectancy and determine the distribution of potential lifetime outcomes …
used to estimate life expectancy and determine the distribution of potential lifetime outcomes …
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
…, J Gatell, AN Phillips, B Ledergerber, JD Lundgren… - Aids, 2010 - journals.lww.com
Objectives: Chronic kidney disease (CKD) in HIV-positive persons might be caused by both
HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term …
HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term …
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
…, C Pradier, B Ledergerber, JD Lundgren… - Aids, 1999 - journals.lww.com
Objectives: To describe changes in haemoglobin over time and to determine the joint prognostic
value of the current haemoglobin, CD4 lymphocyte count and viral load among patients …
value of the current haemoglobin, CD4 lymphocyte count and viral load among patients …